skip to main content

Rogel Cancer Center names 2 new leaders to enhance patient care at U-M and statewide

The University of Michigan Health Rogel Cancer Center has named David C. Smith, M.D., chief medical officer and associate director for cancer clinical services, and Shruti Jolly, M.D., associate director for the Michigan Medicine statewide cancer network.

$7.6 million gift launches new lung cancer research initiative at U-M

A $7.6 million gift from Judith L. Tam and the Richard Tam Foundation has launched an accelerated research initiative here at the Rogel Cancer Center to understand why alterations in the ALK gene causes lung cancer to become resistant to standard therapy over time.

Ronald Weiser Center for Prostate Cancer at Michigan Medicine Established with $30M Gift

The Ronald Weiser Center for Prostate Cancer will aim to elevate and optimize the health care experience for patients with prostate cancer and their families.

Maintaining cellular health and function may come down to one protein

Inside our cells is a complex networks of signals, proteins that need to get to the right place at the right time. And to get there, many rely on a type of protein called kinesins. A study led by the University of Michigan has uncovered unexpected details about a key regulator of this cellular traffic.

Researchers find two markers can predict head and neck cancer outcomes

A new study from the University of Michigan Health Rogel Cancer Center finds circulating tumor DNA, or ctDNA, levels can predict as early as two weeks after starting treatment which patients are likely to have good outcomes.

Rogel Cancer Center earns prestigious rectal cancer accreditation

The University of Michigan Health Rogel Cancer Center has earned a three-year accreditation from the National Accreditation Program for Rectal Cancer, a quality program of the American College of Surgeons’ Commission on Cancer. This recognition signals advanced technical expertise and multidisciplinary care for rectal cancer.

Pages